Saeed, A., Zhang, J., Bashir, B., Philipovskiy, A., Lentz, R. W., Amsili, S., Tabakman, R., Marinova, M., Shwartz, Y., Foley-Comer, A., Jimeno, A. (2025). Phase 2 dose expansion study of DSP107, a first-in-class bi-specific 4-1BB T-cell engager, with and without atezolizumab in metastatic MSS colorectal cancer patients.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3517